370 related articles for article (PubMed ID: 19229678)
1. White matter hyperintensities on T2-weighted MRI images among DNA-verified older familial hypercholesterolemia patients.
Hyttinen L; Autti T; Rauma S; Soljanlahti S; Vuorio AF; Strandberg TE
Acta Radiol; 2009 Apr; 50(3):320-6. PubMed ID: 19229678
[TBL] [Abstract][Full Text] [Related]
2. Statin-treated familial hypercholesterolemia patients with coronary heart disease and pronounced atherosclerosis do not have more brain lesions than healthy controls in later middle age.
Soljanlahti S; Raininko R; Hyttinen L; Lauerma K; Keto P; Vuorio AF; Autti T
Acta Radiol; 2007 Oct; 48(8):894-9. PubMed ID: 17924220
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in elderly patients with familial hypercholesterolemia.
Hyttinen L; Kekäläinen P; Vuorio AF; Sintonen H; Strandberg TE
Int J Technol Assess Health Care; 2008; 24(2):228-34. PubMed ID: 18400127
[TBL] [Abstract][Full Text] [Related]
4. Long-term statin therapy is associated with better episodic memory in aged familial hypercholesterolemia patients in comparison with population controls.
Hyttinen L; TuulioHenriksson A; Vuorio AF; Kuosmanen N; Härkänen T; Koskinen S; Strandberg TE
J Alzheimers Dis; 2010; 21(2):611-7. PubMed ID: 20571223
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, incidence, and risk factors of lacunar infarcts in a community sample.
Chen X; Wen W; Anstey KJ; Sachdev PS
Neurology; 2009 Jul; 73(4):266-72. PubMed ID: 19636046
[TBL] [Abstract][Full Text] [Related]
6. Effect of white matter hyperintensities on cortical cerebral blood volume using perfusion MRI.
Wen W; Sachdev P; Shnier R; Brodaty H
Neuroimage; 2004 Apr; 21(4):1350-6. PubMed ID: 15050560
[TBL] [Abstract][Full Text] [Related]
7. [Regional cerebral blood flow and periventricular hyperintensity in silent cerebral infarction--comparison with multi-infarct dementia].
Koshi Y; Kitamura S; Nagazumi A; Tsuganesawa T; Terashi A
Rinsho Shinkeigaku; 1996 Jun; 36(6):746-51. PubMed ID: 8937195
[TBL] [Abstract][Full Text] [Related]
8. Do statins reduce the incidence of stroke in familial hypercholesterolemia?
Vuorio AF; Kovanen PT
Expert Rev Cardiovasc Ther; 2011 Mar; 9(3):349-53. PubMed ID: 21438814
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence of cervical and cerebral atherosclerosis and silent brain infarction in patients with multivessel coronary artery disease].
Uekita K; Funayama N; Nishiura T; Makiguchi N; Sakamoto N; Aoyama H; Kataoka R; Hasebe N; Kikuchi K
J Cardiol; 2001 Jul; 38(1):13-20. PubMed ID: 11496431
[TBL] [Abstract][Full Text] [Related]
10. Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD.
Martinez-Vea A; Salvadó E; Bardají A; Gutierrez C; Ramos A; García C; Compte T; Peralta C; Broch M; Pastor R; Angelet P; Marcas L; Saurí A; Oliver JA
Am J Kidney Dis; 2006 Feb; 47(2):241-50. PubMed ID: 16431253
[TBL] [Abstract][Full Text] [Related]
11. Familial hypercholesterolemia patients treated with statins at no increased risk for intracranial vascular lesions despite increased cholesterol burden and extracranial atherosclerosis.
Soljanlahti S; Autti T; Lauerma K; Raininko R; Keto P; Turtola H; Vuorio AF
Stroke; 2005 Jul; 36(7):1572-4. PubMed ID: 15933262
[TBL] [Abstract][Full Text] [Related]
12. [Lipoprotein(a) in heterozygote familial hypercholesterolemia].
Ochoa Sosa CA; Zamora González J; González Hermosillo JA; Ize Lema I; Cardoso Saldaña G; Posadas Romero C
Arch Inst Cardiol Mex; 1994; 64(6):549-55. PubMed ID: 7726691
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands.
Wonderling D; Umans-Eckenhausen MA; Marks D; Defesche JC; Kastelein JJ; Thorogood M
Semin Vasc Med; 2004 Feb; 4(1):97-104. PubMed ID: 15199439
[TBL] [Abstract][Full Text] [Related]
14. [Is detection and treatment of familial hypercholesterolemia indicated in children?].
Bakker HD; Wiegman A; Defesche JC; Kastelein JJ
Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2548-51. PubMed ID: 9555154
[TBL] [Abstract][Full Text] [Related]
15. Suboptimal consideration and management of potential familial hypercholesterolaemia in patients with suspected premature coronary artery disease.
Yudi M; Omera L; McCubbery N; Dick S; Jayasinghe R; Hamilton-Craig I
Singapore Med J; 2012 Mar; 53(3):174-8. PubMed ID: 22434290
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.
Gouw AA; Seewann A; Vrenken H; van der Flier WM; Rozemuller JM; Barkhof F; Scheltens P; Geurts JJ
Brain; 2008 Dec; 131(Pt 12):3286-98. PubMed ID: 18927145
[TBL] [Abstract][Full Text] [Related]
17. [Family and polygenic hypercholesteremia: similarities and differencies according to long-term clinical observations].
Lipovetskiĭ BM
Ter Arkh; 2009; 81(1):61-4. PubMed ID: 19253714
[TBL] [Abstract][Full Text] [Related]
18. Clinical silent cerebral infarct (SCI) in patients with thalassemia diseases assessed by magnetic resonance imaging (MRI).
Metarugcheep P; Chanyawattiwongs S; Srisubat K; Pootrakul P
J Med Assoc Thai; 2008 Jun; 91(6):889-94. PubMed ID: 18697390
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of death in community-dwelling older people with white matter hyperintensities on MRI.
Kerber KA; Whitman GT; Brown DL; Baloh RW
J Neurol Sci; 2006 Dec; 250(1-2):33-8. PubMed ID: 16889799
[TBL] [Abstract][Full Text] [Related]
20. Familial hypercholesterolemia, peripheral arterial disease, and stroke: a HuGE minireview.
Hutter CM; Austin MA; Humphries SE
Am J Epidemiol; 2004 Sep; 160(5):430-5. PubMed ID: 15321839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
